iSpecimen (NASDAQ:ISPC – Get Rating) is one of 44 publicly-traded companies in the “Commercial physical research” industry, but how does it weigh in compared to its peers? We will compare iSpecimen to similar businesses based on the strength of its earnings, analyst recommendations, profitability, institutional ownership, dividends, valuation and risk. Institutional and Insider Ownership 11.6% […]